Stocks · Korea
293780
KOSDAQ
Aptabio Therapeutics
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+13.85%
1M+19.18%
3M+74.56%
6M+8.83%
1Y-4.83%
YTD-15.80%
52W high10,890원
52W low3,870원
From 52W high-27.55%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2023 | 3억 | -164억 | -121억 | -5,055.6% |
| 2024 | 34억 | -189억 | -294억 | -561.0% |
| 2025 | 37억 | -158억 | -163억 | -428.4% |
| Quarterly | ||||
| 2024 4Q | 7억 | -66억 | -104억 | -887.7% |
| 2025 1Q | 4억 | -26억 | -26억 | -687.6% |
| 2025 2Q | 11억 | -41억 | -42억 | -368.5% |
| 2025 3Q | 12억 | -34억 | -31억 | -283.3% |
| 2025 4Q | 10억 | -57억 | -65억 | -569.3% |
| 2026 1Q | 10억 | -61억 | -64억 | -636.6% |
Company
Address: 경기도 용인시 기흥구 흥덕1로 13 타워동 30층(영덕동, 흥덕아이티밸리)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.